|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Due from Sponsor | ||||
| Prepaid expenses | ||||
| Total current assets | ||||
| Long term prepaid insurance | ||||
| Marketable securities held in Trust Account | ||||
| Total Assets | ||||
| Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit | ||||
| Current liabilities | ||||
| Accrued offering costs | ||||
| Accrued expenses | ||||
| Advance from related party | ||||
| Total current liabilities | ||||
| Deferred underwriting fee | ||||
| Total Liabilities | ||||
| Class A ordinary shares subject to possible redemption, 28,750,000 and 28,750,000 shares at redemption value of $10.19 and $10.10 per share as of March 31, 2026 and December 31, 2025, respectively | ||||
| Class A Ordinary Shares | ||||
| Total class A ordinary shares subject to possible redemption, 28,750,000 and 28,750,000 shares at redemption value of $10.19 and $10.10 per share as of March 31, 2026 and December 31, 2025, respectively | ||||
| Shareholders’ Deficit | ||||
| Ordinary shares, value | ||||
| Class A Ordinary Shares | ||||
| Class B Ordinary Shares | ||||
| Accumulated deficit | ||||
| Total Shareholders’ Deficit | ||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit |
Loading...
